News Medical on MSN4d
Scientists analyze virus protein structure to advance RSV vaccines
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) ...
Macau Business1h
ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610,...
(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...
Science Daily5d
Researchers use biophysics to design new vaccines against RSV and related respiratory viruses
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...
News Medical5d
New approach to stabilize RSV protein could lead to better vaccines
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses ...
cidrap.umn2d
US respiratory virus activity remains low ahead of holiday season
Respiratory virus activity remained low in the United States last week, with COVID levels continuing to decline, but ...
Vaccination rates for flu and Covid are low this season, CDC says
Vaccination rates for Covid and the flu are low for adults in the U.S. so far this season, according to a new CDC report.
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...